To identify whether PRMT5 was expressed in laryngeal carcinoma and correlated with patient prognosis, a cohort of clinical samples (n = 88, Table S1) from laryngeal carcinoma and matched normal adjacent tissues were analyzed by immunohistochemistry. The gene discussed is PRMT5; the disease is laryngeal carcinoma.